Search

everythinglearnresearchcommunity

for

Search:↓

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Docetaxel is effective against various cancers but mainly causes neutropenia.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Photobiomodulation helps protect hair follicle cells from damage caused by DHT.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Bimekizumab effectively treated a man's chronic beard hair loss.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

A woman with severe angioedema improved significantly after treatment with rituximab.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.